Abstract
Research on selective melanoma neutron capture therapy was initiated by Y. Mishima and his associates, consisting of physicists, chemists, pharmacologists, radiobiologists, and medical scientists. Following basic research of 13 years, this team started the first clinical. trial of melanoma BNCT using10B-paraboronophenylalanine (BPA) in 1987 and have treated 16 patients with various types of melanoma1−4.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Y. Mishima, M. Ichihashi, S. Hatta, C. Honda, K. Yamamura, and T. Nakagawa. New thermal neutron capture therapy for malignant melanoma: Melanogenesis-seeking 15H molecule-melanoma cell interaction from in vitro to first clinical trial. Pigment Cell Res 2, 226–234, 1989.
H. Fukuda, T. Kobayashi, J. Hiratsuka, H. Karashima, C. Honda, K. Yamanntra, M. Ichihashi, K. Kanda, Y. Mishima, Estimation of absorbed dose in the covering skin of human melanoma treated by neutron capture therapy. Pigment Cell Res 2: 365–369, 1989.
Y. Mishima, C. Honda, M. Ichihashi, H. Obara, J. Hiratsuka, H. Fukuda, I I. Karashima, T. Kobayashi, K. Kanda, and K. Yoshino, Treatment of malignant melanoma by single thermal neutron capture therapy with melanoma-seeking 15B-compound. Lancet.Aug 12, 388–389, 1989.
Y. Mishima, M. Ichihashi, C. Honda, M. Shiono, T. Nakagawa, Ii. Ohara, J. Shirakawa, J. Hiratsuka, K. Kanda, T. Kobayashi, T. Nozaki, O. Aizawa, T. Sato, H. Karashima, K. Yoshino, H. Fukuda, Advances in the control of human cutaneous primary and metastatic melanoma by thermal neutron capture therapy. In Progress in Neutron Capture Therapy for Cancer (B.J. Allen, D.E. Moore, B.V. Harrington, eds), pp. 577–583. Plenum Press, New York, London, 1992.
J. Overgaard, The role of radiotherapy in recurrent and metastatic malignant melanoma: A clinical radiobiological study. hit J Radiat Oncol Biol Phys 12, 867–872, 1986
B.G. Douglas, Implication of the quadratic cell survival curve and human skin radiation “tolerance dose” on fractionation and superfractionation dose selection. Intl Radiat Oncol Biol Phys 8, 1135–1142, 1982.
J. Hiratsuka, H. Fukuda, T. Kobayashi, H. Karashima, K. Yoshino, Y. Imajo, and Y. Mishima, The relative biological effectiveness of 10B-neutron capture therapy for early skin reaction in the hamster. Radial Res 128, 186–191, 1991.
H. Fukuda, K. Ando, C. Honda, M. Ichihashi, Y. Mishima, J. Hiratsuka, T. Kobayashi, and K. Kanda, Tolerance limits of the normal skin treated by a single thermal neutron capture therapy. In Progress in Neutron Capture Therapy Jim Cancer.(B.J. Allen, D.E. Moore, B.V. Harrington, eds), pp. 511–514. Plenum Press, New York, London, 1992.
H. Fukuda, J. Hiratsuka, C. Honda, T. Kobayashi, K. Yoshino, H. Karashima, J. Takahashi, Y. Abe, K. Kanda, M. Ichihashi and Y. Mishima, Boron neutron capture therapy of malignant melanoma using 10B-paraboronophenylalanine with special reference to evaluation of radiation dose and damage to the normal skin. Radial Res 138, 435–442, 1994
H. J. Havermalz: Irradiation of malignant melanoma: Experience in the past and present. Int.1 Radial Oncol Biol Phys 7, 131–133, 1981.
R. Ben-Yosef and D.S. Kapp: Prognostic factors in metastatic malignant melanoma treated with combined radiation therapy and hyperthermia. In! J Hvperthermia 6, 767–781, 1993.
J. A. Coderrc, D. N. Slatkin, P. L. Micca and J.R. Ciallella: Boron neutron capture therapy of a murine melanoma with p-boronophenylalanine: dose-response analysis using a morbidity index. Radial Res 128, 177–185, 1991.
G. R. Solares, R. G. Zammenhof, D. E. Wazer, T. A. DiPetrillo, S. C. Saris, G. Cano, H. Madoc-Jones and O.K. Harling: Effects of fraction of boron neutron capture therapy in a mouse model. In Advances in Nuetron Capture Therapv:(A. H. Soloway, R. F. Barth and D. E. Carpenter, eds), pp 525–528, Plenum Press, New York, 1993.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer Science+Business Media New York
About this chapter
Cite this chapter
Fukuda, H. et al. (1996). BNCT of Malignant Melanoma-Radiobiological Analysis and Data Comparison with Conventional Radiotherapy. In: Mishima, Y. (eds) Cancer Neutron Capture Therapy. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-9567-7_95
Download citation
DOI: https://doi.org/10.1007/978-1-4757-9567-7_95
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-9569-1
Online ISBN: 978-1-4757-9567-7
eBook Packages: Springer Book Archive